PATENT CLAIM ANALYSIS

Application Number: 15897926
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["546", "002000"]

Abstract:
The present invention relates to improved processes for the preparation of ruthenium or osmium complexes comprising P and N donor ligands, in particular, ruthenium complexes.

Claim (Index 17):
A [M(X) 2 (L 1 )(L 2 )] complex, wherein:\n M is ruthenium or osmium; X is an anionic ligand; L 1  is a chiral bidentate phosphorus ligand that is: (i) a ligand of formula (Ia) or (Ib): wherein:\n R 20  and R 21  are each, independently, unsubstituted C 3-20 -cycloalkyl, substituted C 3-20 -cycloalkyl, unsubstituted C 5-20 -aryl or substituted C 5-20 -aryl; \n (ii) a ligand of formula (IIa) or (IIb): wherein,\n R 22  and R 23  are, independently, unsubstituted C 1-20 -alkyl, substituted C 1-20 -alkyl, unsubstituted C 3-20 -cycloalkyl, substituted C 3-20 -cycloalkyl, unsubstituted C 1-20 -alkoxy, substituted C 1-20 -alkoxy, unsubstituted C 5-20 -aryl, substituted C 5-20 -aryl, unsubstituted C 1-20 -heteroalkyl, substituted C 1-20 -heteroalkyl, unsubstituted C 2-20 -heterocycloalkyl, substituted C 2-20 -heterocycloalkyl, unsubstituted C 4-20 -heteroaryl or substituted C 4-20 -heteroaryl; \n R 24  and R 25  are, independently, unsubstituted C 1-20 -alkyl, substituted C 1-20 -alkyl, unsubstituted C 3-20 -cycloalkyl, substituted C 3-20 -cycloalkyl, unsubstituted C 1-20 -alkoxy, substituted C 1-20 -alkoxy, unsubstituted C 5-20 -aryl, substituted C 5-20 -aryl, unsubstituted C 1-20 -heteroalkyl, substituted C 1-20 -heteroalkyl, unsubstituted C 2-20 -heterocycloalkyl, substituted C 2-20 -heterocycloalkyl, unsubstituted C 4-20 -heteroaryl or substituted C 4-20 -heteroaryl; \n R 26  is unsubstituted C 1-20 -alkyl or substituted C 1-20 -alkyl; and \n L 2  is a bidentate N,N ligand that is ligand (1), (2) or (3): wherein:\n R 31  and R 32 , R 41  and R 42 , and R 51  and R 52  are, independently, \u2014H, unsubstituted C 1-20 -alkyl, substituted C 1-20 -alkyl, unsubstituted C 3-20 -cycloalkyl, substituted C 3-20 -cycloalkyl, unsubstituted C 1-20 -alkoxy, substituted C 1-20 -alkoxy, unsubstituted C 5-20 -aryl, substituted C 5-20 -aryl, unsubstituted C 1-20 -heteroalkyl, substituted C 1-20 -heteroalkyl, unsubstituted C 2-20 -heterocycloalkyl, substituted C 2-20 -heterocycloalkyl, unsubstituted C 4-20 -heteroaryl or substituted C 4-20 -heteroaryl; \n R 33  and R 34 , R 43  and R 44 , and R 53  and R 54  are \u2014H, unsubstituted C 1-20 -alkyl, substituted C 1-20 -alkyl, unsubstituted C 3-20 -cycloalkyl, substituted C 3-20 -cycloalkyl, unsubstituted C 1-20 -alkoxy, substituted C 1-20 -alkoxy, unsubstituted C 5-20 -aryl, substituted C 5-20 -aryl, unsubstituted C 1-20 -heteroalkyl, substituted C 1-20 -heteroalkyl, unsubstituted C 2-20 -heterocycloalkyl, substituted C 2-20 -heterocycloalkyl, unsubstituted C 4-20 -heteroaryl or substituted C 4-20 -heteroaryl; \n R 35 , R 45 , R 46 , R 55 , R 56  and R 57  are, independently, \u2014H, unsubstituted C 1-20 -alkyl, substituted C 1-20 -alkyl, unsubstituted C 3-20 -cycloalkyl, substituted C 3-20 -cycloalkyl, unsubstituted C 1-20 -alkoxy, substituted C 1-20 -alkoxy, unsubstituted C 5-20 -aryl, substituted C 5-20 -aryl, unsubstituted C 1-20 -heteroalkyl, substituted C 1-20 -heteroalkyl, unsubstituted C 2-20 -heterocycloalkyl, substituted C 2-20 -heterocycloalkyl, unsubstituted C 4-20 -heteroaryl or substituted C 4-20 -heteroaryl; \n c is 0, 1, 2, 3 or 4; \n d is 0, 1,2 or 3; \n e is 0, 1, 2, 3, 4 or 5; \n f is 0, 1 or 2; \n g is 0, 1 or 2; \n h is 0, 1, 2, 3 or 4, \n provided that the complex is not [RuCl 2  (TolBINAP) (2-(aminomethyl)pyridine)]; the ligand of formula (IIa) is not (R)-1-[(S)-2-di(phenylphosphino)ferrocenyl]ethyldicyclohexylphosphine; the ligand of formula (IIb) is not (S)-1-[(R)-2-di(phenylphosphino)ferrocenyl]ethyldicyclohexylphosphine; the ligand of formula (IIa) is not (R)-1-[(S)-2-di(phenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine; and the ligand of formula (IIb) is not (S)-1-[(R)-2-di(phenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 88.0
- Lexical Diversity: 1.12
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15577848', '15039295', '11227479', '14234781', '13821162']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7756004873359859
- 35 USC 102 Novelty (BERT): 0.6222510029038522
- Combined Prediction Score: 0.7602655388927725
- Mean Citation Score: 401.567806
- Max Citation Score: 571.8643
- Similarity Product: 516.3683741382956

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test